Expert Think Tank: Resources to Improve the Care of Patients With NSCLC and EGFR Mutations

In this module, 5 lung cancer experts review oncology healthcare professional survey results on key educational needs for the multidisciplinary oncology team caring for patients with EGFR-mutated NSCLC, including discussion of standard-of-care practices, the latest clinical data, and ongoing challenges.

Edward B. Garon, MD, MS
Program Director Xiuning Le, MD, PhD Zofia Piotrowska, MD, MHS Mark A. Socinski, MD Helena A. Yu, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: September 30, 2022 Expired: September 29, 2023

Downloadable slides capturing key data on standard-of-care practices and ongoing challenges for the multidisciplinary oncology team caring for patients with EGFR-mutated NSCLC as identified by 5 lung cancer experts.

Edward B. Garon, MD, MS
Program Director Xiuning Le, MD, PhD Zofia Piotrowska, MD, MHS Mark A. Socinski, MD Helena A. Yu, MD Released: September 30, 2022

Review an expert’s perspective on novel combination therapies and antibody–drug conjugates for the treatment of patients with EGFR-mutated advanced NSCLC in the first-line setting and beyond, including emerging data and key ongoing trials.

Catherine A. Shu, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 30, 2022 Expired: September 29, 2023

Download these slides for emerging data and a summary of key ongoing clinical trials evaluating novel combination therapies and antibody–drug conjugates for patients with EGFR-mutated advanced NSCLC in the first-line setting and beyond.

Catherine A. Shu, MD Released: September 30, 2022